UBQLN2 and amyotrophic lateral sclerosis: Of note, transgenic mice expressing intermediate levels of P506T-UBQLN2, which causes an aggressive early-onset form of ALS/FTD, did present with alterations in ubiquitin-dependent protein homoeostasis and the formation of widespread neuronal inclusions but lacked clear signs of neurodegeneration [224].